Indication
Crohn's disease
Crohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon. Read more about Crohn's disease
502 drugs 186 manufacturers
Drugs that treat it
Common Crohn's disease therapies.
PREDNISONE
DEXAMETHASONE SODIUM PHOS (PF) (dexamethasone sodium phosphate/PF)
DXEVO (dexamethasone)
SKYRIZI (risankizumab-rzaa)
KENALOG-80 (triamcinolone acetonide)
RINVOQ ER (upadacitinib)
DEXAMETHASONE SODIUM PHOS (PF) (dexamethasone sodium phosphate/PF)
RINVOQ (upadacitinib)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCrohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon.
It typically follows a relapsing and remitting course marked by patchy "skip lesions," abdominal pain, chronic diarrhea, fatigue, and weight loss.
Pathophysiologically driven by immune dysregulation, genetic susceptibility, and environmental factors, the transmural nature of the inflammation frequently leads to structural complications such as strictures, fistulas, abscesses, and bowel obstructions.
- medlineplus.gov
Crohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon
- cancer.gov
Crohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon It typically follows a relapsing and remitting course marked by patchy "skip lesions," abdominal pain, chronic diarrhea, fatigue, and weight loss
- nih.gov
It typically follows a relapsing and remitting course marked by patchy "skip lesions," abdominal pain, chronic diarrhea, fatigue, and weight loss Pathophysiologically driven by immune dysregulation, genetic susceptibility, and environmental factors, the transmural nature of the inflammation frequently leads to structural complications such as strictures, fistulas, abscesses, and bowel obstructions
Personalize your experience
Follow Crohn's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.